Mitsubishi UFJ Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,621
| Closed | -$193K | – | 1128 |
|
|
2023
Q1 | $193K | Buy |
2,621
+244
| +10% | +$17.9K | ﹤0.01% | 1028 |
|
|
2022
Q4 | $157K | Sell |
2,377
-1,193
| -33% | -$78.8K | ﹤0.01% | 1049 |
|
|
2022
Q3 | $192K | Buy |
3,570
+239
| +7% | +$12.9K | ﹤0.01% | 1027 |
|
|
2022
Q2 | $185K | Buy |
3,331
+918
| +38% | +$51K | ﹤0.01% | 1049 |
|
|
2022
Q1 | $169K | Buy |
2,413
+252
| +12% | +$17.6K | ﹤0.01% | 1079 |
|
|
2021
Q4 | $204K | Sell |
2,161
-848
| -28% | -$80.1K | ﹤0.01% | 1083 |
|
|
2021
Q3 | $262K | Hold |
3,009
| – | – | ﹤0.01% | 1024 |
|
|
2021
Q2 | $246K | Sell |
3,009
-2,403
| -44% | -$196K | ﹤0.01% | 1068 |
|
|
2021
Q1 | $515K | Buy |
5,412
+1,807
| +50% | +$172K | ﹤0.01% | 885 |
|
|
2020
Q4 | $224K | Buy |
3,605
+1,318
| +58% | +$81.9K | ﹤0.01% | 942 |
|
|
2020
Q3 | $136K | Buy |
2,287
+17
| +0.7% | +$1.01K | ﹤0.01% | 937 |
|
|
2020
Q2 | $158K | Buy |
2,270
+292
| +15% | +$20.3K | ﹤0.01% | 916 |
|
|
2020
Q1 | $90K | Buy |
1,978
+288
| +17% | +$13.1K | ﹤0.01% | 935 |
|
|
2019
Q4 | $107K | Buy |
1,690
+137
| +9% | +$8.67K | ﹤0.01% | 949 |
|
|
2019
Q3 | $96K | Buy |
1,553
+285
| +22% | +$17.6K | ﹤0.01% | 909 |
|
|
2019
Q2 | $90K | Sell |
1,268
-34
| -3% | -$2.41K | ﹤0.01% | 927 |
|
|
2019
Q1 | $102K | Buy |
1,302
+159
| +14% | +$12.5K | ﹤0.01% | 872 |
|
|
2018
Q4 | $95K | Buy |
1,143
+289
| +34% | +$24K | ﹤0.01% | 859 |
|
|
2018
Q3 | $146K | Buy |
+854
| New | +$146K | ﹤0.01% | 809 |
|